ERBB2 and breast carcinoma: Incongruous findings may depend on the assay methods, HPV prevalence, and geographic differences [14-16]; besides, very few studies evaluated the association between HPV infection and breast cancer clinical-pathologic features, such as histologic subtypes, tumor grade, hormone receptors expression and Human Epidermal Growth Factor Receptor 2 (HER2) status [17-19].